Results 151 to 160 of about 32,558 (212)

Intranasal delivery of mRNA expressing newly identified Acinetobacter baumannii antigens protects against bacterial lung disease. [PDF]

NPJ Vaccines
Higham SL, Wang Z, Murugaiah V, Song J, Thomas C, Zhang H, Griesenbach U, Alton EWFW, Granger LA, Esparza AF, Barbieri BD, Hitchen PG, Kellam P, Shattock RJ, Sriskandan S, Reece ST, Tregoning JS.   +16 more
europepmc   +1 more source

Investigating Strategies to Enhance the Aqueous Solubility of Ketamine HCl for Intranasal Delivery. [PDF]

Pharmaceutics
Idoudi S, Saleh A, Akkbik M, Amine L, Alansari K, Rachid O, Alkilany AM.   +6 more
europepmc   +1 more source

Multilayer Adjuvanted Influenza Protein Nanoparticles Improve Intranasal Delivery and Antigen-Specific Immunity. [PDF]

ACS Nano
Park J, Pho T, Bhatnagar N, Mai LD, Rodriguez-Otero MR, Pal SS, Le CTT, Jenison SE, Li C, May GA, Arioka M, Kang SM, Champion JA.   +12 more
europepmc   +1 more source

Novel intranasal delivery of sihosogansan demonstrates rapid antidepressant activity via GABAergic and BDNF/TrkB pathways: identification of potential bioactive quality markers. [PDF]

Chin Med
Tran KN, Munni YA, Nguyen LTH, Oh TW, Choi HJ, Moon IS, Yang IJ.   +6 more
europepmc   +1 more source

Uptake of Mesenchymal Stem Cell-Derived Exosomes in Mouse Brain through Intranasal Delivery. [PDF]

Curr Drug Deliv
Zhang Z, He S, Jiang W, Lu J, Liu S, Xu W, Wang Z, Lu F, Xiao Q, Zhang J.   +9 more
europepmc   +1 more source

Intranasal delivery of blackberry-loaded Chitosan nanoparticles for antipsychotic potential in Ketamine-induced schizophrenia in rats. [PDF]

Sci Rep
George MY, Farag N, Menze ET, Elezaby RS, Salem NA, Elrahmany SK, Adel N, ElKhatib RM, Galal M, Assem H, Elkhouly R, Wesa MA, Hesham N, Hossam N, Ayoub IM.   +14 more
europepmc   +1 more source

Intranasal Delivery of a Ghrelin Mimetic Engages the Brain Ghrelin Signaling System in Mice.

Endocrinology
Poelman R, Le May MV, Schéle E, Stoltenborg I, Dickson SL.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Intranasal delivery of antipsychotic drugs

Schizophrenia Research, 2017
Antipsychotic drugs are used to treat psychotic disorders that afflict millions globally and cause tremendous emotional, economic and healthcare burdens. However, the potential of intranasal delivery to improve brain-specific targeting remains unrealized. In this article, we review the mechanisms and methods used for brain targeting via the intranasal (
Yogesh K. Katare, Justin E. Piazza, Jayant Bhandari, Ritesh P. Daya, Kosalan Akilan, Madeline J. Simpson, Todd Hoare, Ram K. Mishra   +7 more
openaire   +4 more sources

Intranasal delivery: Physicochemical and therapeutic aspects

International Journal of Pharmaceutics, 2007
Interest in intranasal (IN) administration as a non-invasive route for drug delivery continues to grow rapidly. The nasal mucosa offers numerous benefits as a target issue for drug delivery, such as a large surface area for delivery, rapid drug onset, potential for central nervous system delivery, and no first-pass metabolism.
Henry R, Costantino, Lisbeth, Illum, Gordon, Brandt, Paul H, Johnson, Steven C, Quay   +4 more
openaire   +4 more sources

Intranasal delivery to the brain

Nature Biotechnology, 2011
Robert I Henkin
openaire   +4 more sources